Virus Filtratin Market Size, Share & Trends Analysis Reprt and Segment Frecast, 2026 Grand View Research, Inc The glbal assisted walking device market is expected t reach ver USD 2.0 billin by 2024 accrding t a new reprt by Grand View Research, Inc. The glbal Virus Filtratin Market size is expected t reach USD 7.0 billin by 2026, accrding t a new reprt by Grand View Research, Inc. It is anticipated t register a CAGR f 12.7% during the frecast perid. Increasing demand fr bilgical prducts such as vaccines, therapeutic prteins, bld and bld prducts, cellular and gene therapy, tissue, and stem cell prducts is a majr factr driving the grwth. Bipharmaceuticals are mainly derived frm human, animal, and plants and therefre require a scrutinized virus filtratin prcedure t avid virus cntaminatin in the prductin. Therefre, the necessity f this prcedure during the prductin f bilgics is expected t bst the market grwth. Many leading bipharmaceuticals and bitechnlgy manufacturers are invlved in R&D t develp innvative bilgical prducts. Fr instance, in 2016, Pfizer Inc. invested USD 7,872.0 millin in R&D, which was arund 8% mre than the R&D investment in 2015. This investment was mainly made t bst innvatin and prductivity in R&D t accmplish a sustainable pipeline f vaccines and differentiated therapies with lucrative cmmercial pprtunities. Virus filtratin is an imprtant step in bilgics develpment, thus, increasing R&D n bilgics is expected t drive the prduct demand. T request a sample cpy r view summary f this reprt, click the link belw: https://www.grandviewresearch.cm/industry-analysis/virus-filtratin-market Further key findings frm the reprt suggest:
Cnsumables was the largest revenue generating segment in 2018 wing t the increased usage f cnsumables including reagents, kits, and membranes in bilgics dwnstream prcessing Chrmatgraphy technlgy segment is prjected t expand at the fastest CAGR during the frecast perid, wing t advancements such as dispsable r single-use membranes that eliminate the risk f a ptential virus cntaminant Bilgicals segment held the largest market share in 2018 and is prjected t maintain its dminance during the frecast perid due t rising prevalence f chrnic diseases such as cancer, bld disrders, and diabetes The bitechnlgy and bipharmaceutical cmpanies segment is prjected t expand at the fastest CAGR ver the frecast perid wing t increasing investment in R&D and prductin f bilgics Nrth America led the virus filtratin market in 2018 primarily due t the presence f several leading bitechnlgy cmpanies and increased R&D activities Asia Pacific is estimated t expand at the highest CAGR during the frecast perid. Grwing presence f CROs in cuntries including China and India due t the presence f a large genme pl, less stringent regulatins, and availability f ecnmical labr frce is cntributing t the reginal grwth Sme f the majr players are Merck KGaA; Sartrius; Danaher; Therm Fisher Scientific, Inc.; Charles River Labratries Internatinal, Inc.; GE Healthcare; Asahi Kasei Medical C., Ltd.; WuXi PharmaTech (Cayman) Inc.; Lnza; and Clean Cells Grand View Research has segmented the glbal virus filtratin market n the basis f prduct, technlgy, applicatin, end use, and regin: Virus Filtratin Prduct Outlk (Revenue, USD Millin, 2015-2026) Cnsumables Kits and reagents Others Instruments Filtratin systems Chrmatgraphy systems Services
Virus Filtratin Technlgy Outlk (Revenue, USD Millin, 2015-2026) Filtratin Cnsumables Instruments Services Chrmatgraphy Cnsumables Instruments Services Virus Filtratin Applicatin Outlk (Revenue, USD Millin, 2015-2026) Bilgicals Vaccines and therapeutics Bld and bld prducts Cellular and gene therapy prducts Tissue and tissue prducts Stem cell prducts Medical devices Water purificatin Air purificatin Virus Filtratin End Use Outlk (Revenue, USD Millin, 2015-2026) Bipharmaceutical & bitechnlgy cmpanies Cntract research rganizatins Medical devices cmpanies
Academic institutes & research labratries Virus Filtratin Reginal Outlk (Revenue, USD Millin, 2015-2026) Nrth America U.S. Canada Eurpe Germany U.K. France Italy Spain Russia Asia Pacific Japan China India Suth Krea Australia Singapre Latin America Brazil Mexic Argentina MEA
Suth Africa Saudi Arabia UAE
Table f Cntent f Virus Filtratin Market Chapter 1 Methdlgy and Scpe 1.1 Market Segmentatin & Scpe 1.2 Market Definitin 1.3 Infrmatin Prcurement 1.3.1 Purchased database 1.3.2 GVR s internal database 1.3.3 Secndary surces & third party perspectives 1.3.4 Primary research 1.4 Infrmatin Analysis 1.4.1 Data Analysis Mdels 1.5 Market frmulatin & data visualizatin 1.6 Data Validatin & Publishing Chapter 2 Executive Summary 2.1 Market Outlk 2.2 Segment Outlk 2.3 Cmpetitive Insights Chapter 3 Market Variables, Trends & Scpe 3.1 Market Lineage Outlk 3.1.1 Parent market utlk 3.1.2 Related/ancillary market utlk 3.2 Penetratin & Grwth Prspect Mapping 3.3 Industry Value Chain Analysis 3.3.1 Raw Material Trends 3.3.1.1 Majr Raw Materials Market Analysis 3.3.1.2 Prcurement Best Practices 3.3.2 Manufacturing Trends 3.3.2.1 Technlgy Trends 3.3.2.2 Outsurcing & Cntract Manufacturing Trends 3.3.2.3 Cst Structure Analysis
3.3.3 User perspective analysis 3.3.3.1 Cnsumer Behavir Analysis 3.3.3.2 Market Influencer Analysis 3.3.4 Prcedure cst analysis/breakdwn 3.3.5 List f Key End-users, by regin / by prduct / by cuntry 3.4 Technlgy Overview 3.4.1 Technlgy Timeline 3.5 Regulatry Framewrk 3.5.1 Reimbursement framewrk 3.5.2 Standards & Cmpliances 3.6 Market Dynamics 3.6.1 Market Driver Analysis 3.6.1.1 Rising demand fr bilgics 3.6.1.2 Increasing R&D investment 3.6.1.3 Cmpliance with regulatry framewrk 3.6.2 Market Restraint Analysis 3.6.2.1 Intense cmpetitin amng vendrs 3.6.3 Industry Opprtunity 3.6.3.1 Grwth in pharmaceutical utsurcing industry 3.6.3.2 Rising adptin f single-use technlgies 3.6.4 Industry Challenges 3.6.4.1 Cmplexity f bilgics 3.7 Virus Filtratin Market Analysis Tls 3.7.1 Industry Analysis Prter s 3.7.1.1 Supplier Pwer 3.7.1.2 Buyer Pwer 3.7.1.3 Substitutin Threat 3.7.1.4 Threat frm new entrant 3.7.1.5 Cmpetitive rivalry 3.7.2 PESTEL Analysis 3.7.2.1 Plitical Landscape
3.7.2.2 Envirnmental Landscape 3.7.2.3 Scial Landscape 3.7.2.4 Technlgy Landscape 3.7.2.5 Legal Landscape 3.7.3 Majr Deals & Strategic Alliances Analysis 3.7.4 Market Entry Strategies 3.7.5 Case Studies Chapter 4 Virus Filtratin Market: Cmpetitive Analysis 4.1 Recent Develpments & Impact Analysis, By Key Market Participants 4.2 Vendr Landscape 4.2.1 List f key distributrs and channel partners 4.2.2 Key custmers 4.2.3 Key cmpany market share analysis, 2018 4.3 Public Cmpanies 4.3.1 Cmpany market psitin analysis 4.3.2 Cmpany market Share/Ranking, by regin 4.3.3 Cmpetitive dashbard analysis 4.3.3.1 Market differentiatrs 4.4 Private cmpanies 4.4.1 List f key emerging cmpanies /technlgy disruptrs/innvatrs 4.4.2 Funding utlk 4.4.3 Reginal netwrk map 4.4.4 Cmpany market psitin analysis 4.4.5 Supplier ranking Chapter 5 Virus Filtratin Market: Prduct Estimates and Trend Analysis 5.1 Definitin and Scpe 5.2 Prduct Market Share Analysis, 2018 & 2026 5.3 Segment Dashbard 5.4 Glbal Virus Filtratin Market, by Prduct, 2015-2026 (USD Millin) 5.5 Market Size & Frecasts and Trend Analysis, 2015 t 2026, by Prduct 5.5.1 Cnsumables
5.5.1.1 Cnsumables market, 2015-2026 (USD Millin) 5.5.1.2 Kits & reagents 5.5.1.2.1 Kits & reagents market, 2015-2026 (USD Millin) 5.5.1.3 Others 5.5.1.3.1 Others market, 2015-2026 (USD Millin) 5.5.2 Instruments 5.5.2.1 Instruments market, 2015-2026 (USD Millin) 5.5.2.3 Filtratin systems 5.5.2.3.1 Filtratin systems market, 2015-2026 (USD Millin) 5.5.2.4 Chrmatgraphy systems 5.5.2.4.1 Chrmatgraphy systems market, 2015-2026 (USD Millin) 5.5.3 Services 5.5.3.1 Services market, 2015-2026 (USD Millin) Chapter 6 Virus Filtratin Market: Technlgy Estimates and Trend Analysis 6.1 Definitin and Scpe 6.2 Technlgy Market Share Analysis, 2018 & 2026 6.3 Segment Dashbard 6.4 Glbal Virus Filtratin Market, by Technlgy, 2015-2026 (USD Millin) 6.5 Market Size & Frecasts and Trend Analysis, 2015 t 2026, by Technlgy 6.5.1 Filtratin 6.5.1.1 Filtratin market, 2015-2026 (USD Millin) 6.5.1.2 Filtratin market, by prduct, 2015-2026 (USD Millin) 6.5.2 Chrmatgraphy 6.5.2.1 Chrmatgraphy market, 2015-2026 (USD Millin) 6.5.2.2 Chrmatgraphy market, by prduct, 2015-2026 (USD Millin) Chapter 7 Virus Filtratin Market: Applicatin Estimates and Trend Analysis 7.1 Definitin and Scpe 7.2 Applicatin Market Share Analysis, 2018 & 2026 7.3 Segment Dashbard 7.4 Glbal Virus Filtratin Market, by Applicatin, 2015-2026 (USD Millin) 7.5 Market Size & Frecasts and Trend Analysis, 2015 t 2026, by Applicatin
7.5.1 Bilgicals 7.5.1.1 Bilgicals market, 2015-2026 (USD Millin) 7.5.1.2 Vaccines and therapeutics 7.5.1.2.1 Vaccines and therapeutics market, 2015-2026 (USD Millin) 7.5.1.3 Bld and bld prducts 7.5.1.3.1 Bld and bld prducts market, 2015-2026 (USD Millin) 7.5.1.4 Cellular and gene therapy prducts 7.5.1.4.1 Cellular and gene therapy prducts market, 2015-2026 (USD Millin) 7.5.1.5 Tissue and tissue prducts 7.5.1.5.1 Tissue and tissue prducts market, 2015-2026 (USD Millin) 7.5.1.6 Stem cell prducts 7.5.1.6.1 Stem cell prducts market, 2015-2026 (USD Millin) 7.5.2 Medical Devices 7.5.2.1 Medical devices market, 2015-2026 (USD Millin) 7.5.3 Water Purificatin 7.5.3.1 Water purificatin market, 2015-2026 (USD Millin) 7.5.4 Air Purificatin 7.5.4.1 Air purificatin market, 2015-2026 (USD Millin) Chapter 8 Virus Filtratin Market: End Use Estimates and Trend Analysis 8.1 Definitin and Scpe 8.2 End Use Market Share Analysis, 2018 & 2026 8.3 Segment Dashbard 8.4 Glbal Virus Filtratin Market, by End Use, 2015-2026 (USD Millin) 8.5 Market Size & Frecasts and Trend Analysis, 2015 t 2026, by End Use 8.5.1 Bipharmaceutical & bitechnlgy cmpanies 8.5.1.1 Bipharmaceutical & bitechnlgy cmpanies market, 2015-2026 (USD Millin) 8.5.2 CROs 8.5.2.1 CROs market, 2015-2026 (USD Millin) 8.5.3 Medical devices cmpanies 8.5.3.1 Medical devices cmpanies market, 2015-2026 (USD Millin) 8.5.4 Academic institutes & research labratries
8.5.4.1 Academic institutes & research labratries market, 2015-2026 (USD Millin) Chapter 9 Virus Filtratin Market Reginal Estimates & Trend Analysis, by Prduct, Technlgy, Applicatin, End Use 9.1 Reginal Market Snapsht 9.2 Reginal Market Share and Leading Players, 2018 9.2.1 Nrth America 9.2.2 Eurpe 9.2.3 Asia Pacific 9.2.4 Latin America 9.2.5 Middle East & Africa 9.3 Market Share Analysis by Cuntry/ State 9.3.1 Nrth America 9.3.2 Eurpe 9.3.3 Asia Pacific 9.3.4 Latin America 9.3.5 Middle East & Africa 9.4 SWOT Analysis, by Factr (Plitical & Legal, Ecnmic and Technlgical) 9.4.1 Nrth America 9.4.2 Eurpe 9.4.3 Asia Pacific 9.4.4 Latin America 9.4.5 Middle East & Africa 9.5 Market Size, & Frecasts and Trend Analysis, 2015 t 2026 9.6 Nrth America 9.6.1 Nrth America Market Size, & Frecasts and Trend Analysis, 2015 t 2026 (USD Millin) 9.6.2 U.S. 9.6.2.1 U.S. Market Size, & Frecasts and Trend Analysis, 2015 t 2026 (USD Millin) 9.6.3 Canada 9.6.3.1 Canada Market Size, & Frecasts and Trend Analysis, 2015 t 2026 (USD Millin) 9.7 Eurpe 9.7.1 Eurpe Market Size, & Frecasts and Trend Analysis, 2015 t 2026 (USD Millin)
9.7.2 Germany 9.7.2.1 Germany Market Size, & Frecasts and Trend Analysis, 2015 t 2026 (USD Millin) 9.7.3 U.K. 9.7.3.1 U.K. Market Size, & Frecasts and Trend Analysis, 2015 t 2026 (USD Millin) 9.7.4 France 9.7.4.1 France Market Size, & Frecasts and Trend Analysis, 2015 t 2026 (USD Millin) 9.7.5 Italy 9.7.5.1 Italy Market Size, & Frecasts and Trend Analysis, 2015 t 2026 (USD Millin) 9.7.6 Spain 9.7.6.1 Spain Market Size, & Frecasts and Trend Analysis, 2015 t 2026 (USD Millin) 9.7.7 Russia 9.7.7.1 Russia Market Size, & Frecasts and Trend Analysis, 2015 t 2026 (USD Millin) 9.8 Asia Pacific 9.8.1 Asia Pacific Market Size, & Frecasts and Trend Analysis, 2015 t 2026 (USD Millin) 9.8.2 Japan 9.8.2.1 Japan Market Size, & Frecasts and Trend Analysis, 2015 t 2026 (USD Millin) 9.8.3 China 9.8.3.1 China Market Size, & Frecasts and Trend Analysis, 2015 t 2026 (USD Millin) 9.8.4 India 9.8.4.1 India Market Size, & Frecasts and Trend Analysis, 2015 t 2026 (USD Millin) 9.8.5 Suth Krea 9.8.6.1 Suth Krea Market Size, & Frecasts and Trend Analysis, 2015 t 2026 (USD Millin) 9.8.7 Australia 9.8.7.1 Australia Market Size, & Frecasts and Trend Analysis, 2015 t 2026 (USD Millin) 9.8.8 Singapre 9.8.8.1 Singapre Market Size, & Frecasts and Trend Analysis, 2015 t 2026 (USD Millin) 9.9 Latin America 9.9.1 Latin America Market Size, & Frecasts and Trend Analysis, 2015 t 2026 (USD Millin) 9.9.2 Brazil 9.9.2.1 Brazil Market Size, & Frecasts and Trend Analysis, 2015 t 2026 (USD Millin) 9.9.3 Mexic
9.9.3.1 Mexic Market Size, & Frecasts and Trend Analysis, 2015 t 2026 (USD Millin) 9.9.4 Argentina 9.9.4.1 Argentina Market Size, & Frecasts and Trend Analysis, 2015 t 2026 (USD Millin) 9.10 Middle East and Africa 9.10.1 Middle East and Africa Market Size, & Frecasts and Trend Analysis, 2015 t 2026 (USD Millin) 9.10.2 Suth Africa 9.10.2.1 Suth Africa Market Size, & Frecasts and Trend Analysis, 2015 t 2026 (USD Millin) 9.10.3 Saudi Arabia 9.10.3.1 Saudi Arabia Market Size, & Frecasts and Trend Analysis, 2015 t 2026 (USD Millin) 9.10.4 UAE 9.10.4.1 UAE Market Size, & Frecasts and Trend Analysis, 2015 t 2026 (USD Millin) Chapter 10 COMPANY PROFILES 10.1 Merck KGaA 10.1.1 Cmpany Overview 10.1.2 Financial perfrmance 10.1.3 Prduct Benchmarking 11.1.4 Strategic Initiatives 10.2 Danaher 10.2.1 Cmpany Overview 10.2.2 Financial perfrmance 10.2.3 Prduct Benchmarking 10.2.4 Strategic Initiatives 10.3 Sartrius AG 10.3.1 Cmpany Overview 10.3.2 Financial perfrmance 10.3.3 Prduct Benchmarking 10.3.4 Strategic Initiatives 10.4 Therm Fisher Scientific Inc. 10.4.1 Cmpany Overview 10.4.2 Financial perfrmance 10.4.3 Prduct Benchmarking
10.4.4 Strategic Initiatives 10.5 GE Healthcare 10.5.1 Cmpany Overview 10.5.2 Financial perfrmance 10.5.3 Prduct Benchmarking 10.5.4 Strategic Initiatives 10.6 Charles River Labratries Internatinal, Inc. 10.6.1 Cmpany Overview 10.6.2 Financial perfrmance 10.6.3 Prduct Benchmarking 10.6.4 Strategic Initiatives 10.7 Asahi Kasei Medical C., Ltd. 10.7.1 Cmpany Overview 10.7.2 Financial perfrmance 10.7.3 Prduct Benchmarking 10.7.4 Strategic Initiatives 10.8 WuXi PharmaTech Inc. 10.8.1 Cmpany Overview 10.8.2 Financial perfrmance 10.8.3 Prduct Benchmarking 10.8.4 Strategic Initiatives 10.9 Lnza Grup Ltd. 10.9.1 Cmpany Overview 10.9.2 Financial perfrmance 10.9.3 Prduct Benchmarking 10.9.4 Strategic Initiatives 10.10 Clean Cells Inc. 10.10.1 Cmpany Overview 10.10.2 Financial perfrmance 10.10.3 Prduct Benchmarking 10.10.4 Strategic Initiatives
Abut Us: Grand View Research, Inc. is a U.S. based market research and cnsulting cmpany, registered in the State f Califrnia and headquartered in San Francisc. The cmpany prvides syndicated research reprts, custmized research reprts, and cnsulting services. T help clients make infrmed business decisins, the cmpany ffers market intelligence studies ensuring relevant and fact-based research acrss a range f industries including technlgy, chemicals, materials, healthcare and energy. Cntact: Sherry James Crprate Sales Specialist, USA Grand View Research, Inc Phne: 1-415- 349-0058 Tll Free: 1-888- 202-9519 Email: sales@grandviewresearch.cm Fr Mre Infrmatin: https://www.grandviewresearch.cm Blg: https://healthcarefrecastreprt.blgspt.cm/